Recently, ZGC Capital signed strategic cooperation agreements with Daxing Biomedicine Industrial Base and Capital Medical University Education Foundation. Under the agreements, ZGC Capital will collaborate with partners to deeply integrate industry, academia and research, empower the entire chain with financial support, facilitate the industrialization of cutting-edge research achievements from laboratories, and promote the high-quality development of the life and health industry.

At present, ZGC Capital focuses on cutting-edge fields such as brain-computer interfaces, synthetic biology, “AI + healthcare”, and genetic technology, with 148 investment projects including 73 strategic sci-tech initiatives.